Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE

Abstract Introduction For chronic diseases such as axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), and plaque psoriasis (PsO), treatment goals include remission or at least low disease activity (LDA) by 12 weeks. Improvements in symptoms such as pain and fatigue should also be treatment...

Полное описание

Библиографические подробности

Главные авторы:	Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaçi, Anja Plenske, Pascal Klaus, Thomas Meng
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Adis, Springer Healthcare 2024-02-01
Серии:	Rheumatology and Therapy
Предметы:	Axial spondyloarthritis Etanercept Plaque psoriasis Psoriatic arthritis Real world Remission
Online-ссылка:	https://doi.org/10.1007/s40744-023-00633-2
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!